Lanzhou Foci Pharmaceutical Co., Ltd. is an enterprise with a history of nearly a hundred years. It was founded in Shanghai in 1929, moved westward to Lanzhou in 1956, and was first listed on the Shenzhen Stock Exchange in 2011. It is a state-owned listed company.

The company has 6 wholly-owned subsidiaries, 1 holding subsidiary and 2 shareholder subsidiaries. There are 467 approved drug production documents, and the drug production line has passed the national drug GMP certification and the Australian TGA organization and the Japanese Ministry of Health, Labor and Welfare. More than 100 Chinese and Western medicine products are produced in 11 dosage forms such as concentrated pills, Dami pills, granules, capsules, tablets, gelatin, etc., and have ginseng and antler Guben Shao pills, compound Astragalus Jianpi oral liquid, bamboo leaves 10 products including pepper flakes.

Foci products are well-known both at home and abroad for their authentic materials selection, excellent craftsmanship, accurate efficacy and easy to take. The products are exported to 29 countries and regions including the United States, Canada, Australia, Japan, Brazil, Hong Kong, etc., with the number of product certifications and overseas trademark registrations. , export coverage and export varieties have long been among the top in the same industry.

As a high-tech enterprise in Gansu Province, the company has three key R&D platforms: Gansu Province Modern Traditional Chinese Medicine Preparation Engineering Technology Research Center, Gansu Province Traditional Chinese Medicine Quality Control Technology Engineering Laboratory and Provincial Enterprise Technology Center, as well as "Academician Wang Yongyan Expert Workstation" and "Zhang Shichen Expert Team Innovative platforms such as the inheritance base for traditional Chinese medicine preparation techniques.

With the vision of "a benchmark enterprise for Chinese traditional medicine quality and the vanguard of revitalizing Long Medicine", the company has established the development strategy of "three-wheel drive" to increase vitality and "six major systems" to promote Long Medicine. Through the three-wheel drive of "operation-driven, innovation-driven, and financial-driven", the company will comprehensively deepen the construction of the "big industry, big market, big production, big brand, big R&D, and big capital" ecological system, and strive to strengthen and expand the manufacturing of Chinese patent medicines. The main business extends the industrial chain and forms a new Foci for the development of the entire industrial chain.